HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myeloid Sarcoma of the Bladder in the Setting of Refractory Anemia with Excess Blasts-2 (RAEB-2).

Abstract
Myeloid sarcoma is an extramedullary tumor consisting of immature hematopoietic cells of granulocytic or monocytic differentiation. While rare, it can be seen in a variety of clinical settings and is most commonly associated with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). We present a rare case of myeloid sarcoma occurring in the bladder of a 56 year old male. Myeloid sarcoma may be difficult to recognize due to its rarity and clinical and morphologic similarity to many other conditions; however, swift diagnosis is necessary as it is considered equivalent to AML. Prognostic indicators for myeloid sarcoma have not been well established, but survival may be improved by undergoing chemotherapy designed to treat AML.
AuthorsJohn T Grantham, David M Howell, Patrick J Bacaj, James E Coad, Jeffrey A Vos
JournalThe West Virginia medical journal (W V Med J) 2015 Nov-Dec Vol. 111 Issue 6 Pg. 34-6 ISSN: 0043-3284 [Print] United States
PMID26665895 (Publication Type: Case Reports, Journal Article)
Topics
  • Anemia, Refractory, with Excess of Blasts (diagnosis, etiology)
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Sarcoma, Myeloid (diagnosis, pathology)
  • Urinary Bladder Neoplasms (diagnosis, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: